Fundz
Real-time · AI · Cross-signal

MANGOCEUTICALS just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on MANGOCEUTICALS, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Mangoceuticals Partners with Eli Lilly and Novo Nordisk

Nov 13, 2025•6 months ago

Contract Type

partnership

DallasOtherBiotechnologyHealth CareDietary SupplementsNutrition

Description

On November 13, 2025, Mangoceuticals, Inc. announced a partnership with Eli Lilly and Novo Nordisk. This collaboration aims to enhance affordable access to their respective medications, Zepbound and Wegovy. The partnership signifies a commitment to making healthcare more accessible

Company Information

Company

MANGOCEUTICALS

Location

4131 N. CENTRAL EXPRESSWAY

Dallas, Georgia, United States

About

MangoRX is a new men’s health and wellness company dedicated to developing, marketing, and selling a variety of men’s wellness products and services via a telemedicine platform that connects consumers to licensed healthcare professionals.

Predictive Intelligence
Strategic

ML-powered predictions for MANGOCEUTICALS's next move

Learn about Strategic plan

Related People

Suggested for you

Choose your plan to reveal verified contacts

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months